Your browser doesn't support javascript.
loading
Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs.
Narayanan, Naveen; Nair, Deepak T.
Afiliação
  • Narayanan N; Laboratory of Genomic Integrity and Evolution, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India; Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
  • Nair DT; Laboratory of Genomic Integrity and Evolution, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad 121001, Haryana, India. Electronic address: deepak@rcb.res.in.
Int J Biol Macromol ; 168: 272-278, 2021 Jan 31.
Article em En | MEDLINE | ID: mdl-33309661

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas não Estruturais Virais / Ritonavir / Exorribonucleases / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas não Estruturais Virais / Ritonavir / Exorribonucleases / SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article